Nuwellis (NUWE) Non-Current Debt (2015 - 2016)

Nuwellis (NUWE) posted Non-Current Debt of $2.0 million for Q2 2016, down 33.03% on a QoQ basis from $2.9 million in Q1 2016.

Nuwellis (NUWE) Non-Current Debt (2015 - 2016) Analysis & Trends

Nuwellis' Non-Current Debt history runs 2 years deep, the most recent figure standing at $2.0 million for Q2 2016.

Quarterly Non-Current Debt changed N/A year-over-year to $2.0 million in Q2 2016, while the trailing twelve-month figure through Jun 2016 was $2.0 million (changed N/A YoY) and the FY2015 annual result came in at $3.9 million, changed N/A from the prior year.
Non-Current Debt was $2.0 million for Q2 2016 at Nuwellis, down from $2.9 million in the prior quarter.
Across five years, Non-Current Debt topped out at $3.9 million in Q4 2015 and bottomed at $2.0 million in Q2 2016.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Current Debt (Qtr)
1	Abbott Laboratories	184.32 Bn	177.02 Bn	6.27 Bn	29.64 Bn
2	Stryker	128.89 Bn	126.01 Bn	3.81 Bn	14.22 Bn
3	Medtronic	108.88 Bn	99.66 Bn	6.41 Bn	26.17 Bn
4	Boston Scientific	68.65 Bn	67.20 Bn	3.61 Bn	10.99 Bn
5	Edwards Lifesciences	47.43 Bn	43.76 Bn	1.29 Bn	598.50 Mn
6	GE HealthCare Technologies	28.48 Bn	26.19 Bn	1.98 Bn	10.13 Bn
7	Dexcom	28.45 Bn	27.33 Bn	750.30 Mn	-
8	Smith & Nephew	26.98 Bn	26.40 Bn	-	3.18 Bn
9	Koninklijke Philips	25.54 Bn	22.42 Bn	2.07 Bn	8.07 Bn
10	Nuwellis	116,994.99	-1.97 Mn	1.68 Mn	-

Download Data